Allergic Rhinitis Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Allergic Rhinitis Market to 2027 - Global Analysis and Forecasts By Drug Class (Antihistamines, Intranasal Corticosteroids, Immunotherapies); Route of Administration (Oral, Parental, Intranasal); Form (Solid, Liquid)

Report Code: TIPRE00004759 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Allergic Rhinitis is also referred as hay fever. Allergic rhinitis is caused because of several allergens such as pollens, mould, animal dander and dust. This is an inherited disease which means that if a parent has the disease it is likely to be present in their offspring too.

MARKET DYNAMICS
The Allergic Rhinitis market is anticipated to grow in the forecast period owing to driving factors such as increasing prevalence of allergic rhinitis, growing awareness about the disease, high usage of tobacco, and increasing prevalence of pollution. Nevertheless, patent expiry and competition from generic drugs are expected to restrict the market growth during the forecast period.

MARKET SCOPE
The "Global Allergic Rhinitis Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Allergic Rhinitis market with detailed market segmentation by Drug Class, Route of Administration, Form and geography. The global Allergic Rhinitis market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Allergic Rhinitis market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Allergic Rhinitis market is segmented on the basis of Drug Class, Route of Administration and Form. Based on Drug Class the market is segmented into Antihistamines, Intranasal Corticosteroids, Immunotherapies. Based on Route of Administration the market is segmented into Oral, Parental, Intranasal. Based on Form the market is segmented into Solid, Liquid.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Allergic Rhinitis market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Allergic Rhinitis market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Allergic Rhinitis market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Allergic Rhinitis market in these regions.

MARKET PLAYERS
The reports cover key developments in the Allergic Rhinitis Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Allergic Rhinitis Market are anticipated to lucrative growth opportunities in the future with the rising demand for Allergic Rhinitis in the global market. Below mentioned is the list of few companies engaged in the Allergic Rhinitis market.

The report also includes the profiles of key Allergic Rhinitis market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Merck
  • GlaxoSmithKline Plc
  • Sanofi
  • Cigna
  • Himalaya
  • Chong kun Dang Pharmaceutical Corp
  • Glenmark Pharmaceutical
  • Hisamitsu Pharmaceutical Co.in
  • Ampio pharmaceutical Inc
  • Olain Farm
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Allergic Rhinitis Market - By Drug Class
1.3.2 Allergic Rhinitis Market - By Route of Administration
1.3.3 Allergic Rhinitis Market - By Form
1.3.4 Allergic Rhinitis Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ALLERGIC RHINITIS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ALLERGIC RHINITIS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ALLERGIC RHINITIS MARKET - GLOBAL MARKET ANALYSIS
6.1. ALLERGIC RHINITIS - GLOBAL MARKET OVERVIEW
6.2. ALLERGIC RHINITIS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ALLERGIC RHINITIS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. ANTIHISTAMINES
7.3.1. Overview
7.3.2. Antihistamines Market Forecast and Analysis
7.4. INTRANASAL CORTICOSTEROIDS
7.4.1. Overview
7.4.2. Intranasal Corticosteroids Market Forecast and Analysis
7.5. IMMUNOTHERAPIES
7.5.1. Overview
7.5.2. Immunotherapies Market Forecast and Analysis
8. ALLERGIC RHINITIS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. PARENTAL
8.4.1. Overview
8.4.2. Parental Market Forecast and Analysis
8.5. INTRANASAL
8.5.1. Overview
8.5.2. Intranasal Market Forecast and Analysis
9. ALLERGIC RHINITIS MARKET - REVENUE AND FORECASTS TO 2027 - FORM
9.1. OVERVIEW
9.2. FORM MARKET FORECASTS AND ANALYSIS
9.3. SOLID
9.3.1. Overview
9.3.2. Solid Market Forecast and Analysis
9.4. LIQUID
9.4.1. Overview
9.4.2. Liquid Market Forecast and Analysis
10. ALLERGIC RHINITIS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Allergic Rhinitis Market Overview
10.1.2 North America Allergic Rhinitis Market Forecasts and Analysis
10.1.3 North America Allergic Rhinitis Market Forecasts and Analysis - By Drug Class
10.1.4 North America Allergic Rhinitis Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Allergic Rhinitis Market Forecasts and Analysis - By Form
10.1.6 North America Allergic Rhinitis Market Forecasts and Analysis - By Countries
10.1.6.1 United States Allergic Rhinitis Market
10.1.6.1.1 United States Allergic Rhinitis Market by Drug Class
10.1.6.1.2 United States Allergic Rhinitis Market by Route of Administration
10.1.6.1.3 United States Allergic Rhinitis Market by Form
10.1.6.2 Canada Allergic Rhinitis Market
10.1.6.2.1 Canada Allergic Rhinitis Market by Drug Class
10.1.6.2.2 Canada Allergic Rhinitis Market by Route of Administration
10.1.6.2.3 Canada Allergic Rhinitis Market by Form
10.1.6.3 Mexico Allergic Rhinitis Market
10.1.6.3.1 Mexico Allergic Rhinitis Market by Drug Class
10.1.6.3.2 Mexico Allergic Rhinitis Market by Route of Administration
10.1.6.3.3 Mexico Allergic Rhinitis Market by Form
10.1.6.4 US Allergic Rhinitis Market
10.1.6.4.1 US Allergic Rhinitis Market by Drug Class
10.1.6.4.2 US Allergic Rhinitis Market by Route of Administration
10.1.6.4.3 US Allergic Rhinitis Market by Form
10.2. EUROPE
10.2.1 Europe Allergic Rhinitis Market Overview
10.2.2 Europe Allergic Rhinitis Market Forecasts and Analysis
10.2.3 Europe Allergic Rhinitis Market Forecasts and Analysis - By Drug Class
10.2.4 Europe Allergic Rhinitis Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Allergic Rhinitis Market Forecasts and Analysis - By Form
10.2.6 Europe Allergic Rhinitis Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Allergic Rhinitis Market
10.2.6.1.1 Germany Allergic Rhinitis Market by Drug Class
10.2.6.1.2 Germany Allergic Rhinitis Market by Route of Administration
10.2.6.1.3 Germany Allergic Rhinitis Market by Form
10.2.6.2 France Allergic Rhinitis Market
10.2.6.2.1 France Allergic Rhinitis Market by Drug Class
10.2.6.2.2 France Allergic Rhinitis Market by Route of Administration
10.2.6.2.3 France Allergic Rhinitis Market by Form
10.2.6.3 Italy Allergic Rhinitis Market
10.2.6.3.1 Italy Allergic Rhinitis Market by Drug Class
10.2.6.3.2 Italy Allergic Rhinitis Market by Route of Administration
10.2.6.3.3 Italy Allergic Rhinitis Market by Form
10.2.6.4 Spain Allergic Rhinitis Market
10.2.6.4.1 Spain Allergic Rhinitis Market by Drug Class
10.2.6.4.2 Spain Allergic Rhinitis Market by Route of Administration
10.2.6.4.3 Spain Allergic Rhinitis Market by Form
10.2.6.5 United Kingdom Allergic Rhinitis Market
10.2.6.5.1 United Kingdom Allergic Rhinitis Market by Drug Class
10.2.6.5.2 United Kingdom Allergic Rhinitis Market by Route of Administration
10.2.6.5.3 United Kingdom Allergic Rhinitis Market by Form
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Allergic Rhinitis Market Overview
10.3.2 Asia-Pacific Allergic Rhinitis Market Forecasts and Analysis
10.3.3 Asia-Pacific Allergic Rhinitis Market Forecasts and Analysis - By Drug Class
10.3.4 Asia-Pacific Allergic Rhinitis Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Allergic Rhinitis Market Forecasts and Analysis - By Form
10.3.6 Asia-Pacific Allergic Rhinitis Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Allergic Rhinitis Market
10.3.6.1.1 Australia Allergic Rhinitis Market by Drug Class
10.3.6.1.2 Australia Allergic Rhinitis Market by Route of Administration
10.3.6.1.3 Australia Allergic Rhinitis Market by Form
10.3.6.2 China Allergic Rhinitis Market
10.3.6.2.1 China Allergic Rhinitis Market by Drug Class
10.3.6.2.2 China Allergic Rhinitis Market by Route of Administration
10.3.6.2.3 China Allergic Rhinitis Market by Form
10.3.6.3 India Allergic Rhinitis Market
10.3.6.3.1 India Allergic Rhinitis Market by Drug Class
10.3.6.3.2 India Allergic Rhinitis Market by Route of Administration
10.3.6.3.3 India Allergic Rhinitis Market by Form
10.3.6.4 Japan Allergic Rhinitis Market
10.3.6.4.1 Japan Allergic Rhinitis Market by Drug Class
10.3.6.4.2 Japan Allergic Rhinitis Market by Route of Administration
10.3.6.4.3 Japan Allergic Rhinitis Market by Form
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Allergic Rhinitis Market Overview
10.4.2 Middle East and Africa Allergic Rhinitis Market Forecasts and Analysis
10.4.3 Middle East and Africa Allergic Rhinitis Market Forecasts and Analysis - By Drug Class
10.4.4 Middle East and Africa Allergic Rhinitis Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Allergic Rhinitis Market Forecasts and Analysis - By Form
10.4.6 Middle East and Africa Allergic Rhinitis Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Allergic Rhinitis Market
10.4.6.1.1 South Africa Allergic Rhinitis Market by Drug Class
10.4.6.1.2 South Africa Allergic Rhinitis Market by Route of Administration
10.4.6.1.3 South Africa Allergic Rhinitis Market by Form
10.4.6.2 Saudi Arabia Allergic Rhinitis Market
10.4.6.2.1 Saudi Arabia Allergic Rhinitis Market by Drug Class
10.4.6.2.2 Saudi Arabia Allergic Rhinitis Market by Route of Administration
10.4.6.2.3 Saudi Arabia Allergic Rhinitis Market by Form
10.4.6.3 U.A.E Allergic Rhinitis Market
10.4.6.3.1 U.A.E Allergic Rhinitis Market by Drug Class
10.4.6.3.2 U.A.E Allergic Rhinitis Market by Route of Administration
10.4.6.3.3 U.A.E Allergic Rhinitis Market by Form
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Allergic Rhinitis Market Overview
10.5.2 South and Central America Allergic Rhinitis Market Forecasts and Analysis
10.5.3 South and Central America Allergic Rhinitis Market Forecasts and Analysis - By Drug Class
10.5.4 South and Central America Allergic Rhinitis Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Allergic Rhinitis Market Forecasts and Analysis - By Form
10.5.6 South and Central America Allergic Rhinitis Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Allergic Rhinitis Market
10.5.6.1.1 Brazil Allergic Rhinitis Market by Drug Class
10.5.6.1.2 Brazil Allergic Rhinitis Market by Route of Administration
10.5.6.1.3 Brazil Allergic Rhinitis Market by Form
10.5.6.2 Argentina Allergic Rhinitis Market
10.5.6.2.1 Argentina Allergic Rhinitis Market by Drug Class
10.5.6.2.2 Argentina Allergic Rhinitis Market by Route of Administration
10.5.6.2.3 Argentina Allergic Rhinitis Market by Form
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ALLERGIC RHINITIS MARKET, KEY COMPANY PROFILES
12.1. MERCK
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. GLAXOSMITHKLINE PLC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SANOFI
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CIGNA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. HIMALAYA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. CHONG KUN DANG PHARMACEUTICAL CORP
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLENMARK PHARMACEUTICAL
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. HISAMITSU PHARMACEUTICAL CO.IN
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. AMPIO PHARMACEUTICAL INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. OLAIN FARM
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

- Merck
- GlaxoSmithKline Plc
- Sanofi
- Cigna
- Himalaya
- Chong kun Dang Pharmaceutical Corp
- Glenmark Pharmaceutical
- Hisamitsu Pharmaceutical Co.in
- Ampio pharmaceutical Inc
- Olain Farm
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book